Viewing 1 - 1 out of 1 posts

Whistleblower Lawsuit Related to Cancer Drug Marketing Leads to Celgene Paying $280 Million

Celgene Corporation, a biotech company based in New Jersey, will pay out $280 million to settle claims that it cited uses not approved by the U.S. Food and Drug Administration Read More

Viewing 1 - 1 out of 1 posts